Rapamycin Inhibition of the Akt/mTOR Pathway Blocks Select Stages of VEGF-A <sup>164</sup> –Driven Angiogenesis, in Part by Blocking S6KinaseQi Xue, Laura E. Benjamin|Arteriosclerosis Thrombosis and Vascular Biology|2009Cited by 100
Endothelial Akt Signaling Is Rate-Limiting for Rapamycin Inhibition of Mouse Mammary Tumor ProgressionThuy L. Phung, Laura E. Benjamin|Cancer Research|2007Cited by 53
Supplemental Methods from Stromal-Based Signatures for the Classification of Gastric CancerMark Uhlik, Laura E. Benjamin|Unknown|2023Cited by 0